Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,085,347
+$134,472 QoQ
Shares Held
8,211
+2.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#2,310
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealth Architects, LLC holds $10,190,838 across 8 Drug Manufacturers - General names. JNJ ranks #2 (20.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,001 | $3,599,489 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
8,211 | $2,085,347 | |
| 3 | MRK |
Merck & Co., Inc.
|
13,630 | $1,751,455 | |
| 4 | ABBV |
AbbVie Inc.
|
4,832 | $1,215,924 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
4,000 | $505,360 | |
| 6 | AMGN |
Amgen Inc
|
1,389 | $502,984 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,655 | $325,841 | |
| 8 | GSK |
GSK plc
|
3,900 | $204,438 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,085,347 | 8,211 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,950,875 | 7,981 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,623,315 | 7,844 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,403,814 | 7,571 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,179,382 | 7,721 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $1,602,843 | 9,665 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,197,308 | 8,279 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,393,553 | 8,599 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $1,282,700 | 8,776 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,343,507 | 8,493 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,297,493 | 8,278 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,350,041 | 8,668 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,407,747 | 8,505 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,273,170 | 8,214 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $1,495,872 | 8,468 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,412,737 | 8,648 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $1,590,312 | 8,959 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,791,972 | 10,111 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $1,295,513 | 7,573 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $1,146,165 | 7,097 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,161,746 | 7,052 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $785,264 | 4,778 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $730,715 | 4,643 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $702,564 | 4,719 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $653,788 | 4,649 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $524,913 | 4,003 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||